Clinical Trial Update: Convection-Enhanced Delivery to Study the Pathophysiology Underlying the Clinical Features of Parkinson s Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating convection-enhanced delivery to study the pathophysiology underlying Parkinson's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Phase 1 | Status: WITHDRAWN